Illumina: Third Quarter Results Highlight Solid Growth Prospects
Long Ideas - One of the most pressing issues that the market faces today is what kind of impact the fiscal cliff will have on companies in the … Continue Reading
Read nowAuthor Archives: Ivan Deryugin
Biogen Idec’s BG-12 PDUFA Delay is a Buying Opportunity
Long Ideas - The biotechnology sector can be broken up, at its simplest, into two distinct groups: the Big 4, and every other company. The Big 4 are … Continue Reading
Read nowDendreon Q3 Earnings Preview: Can the Company Overcome the Odds?
Long Ideas - One of the most controversial companies in the biotechnology sector today is Dendreon (NASDAQ:DNDN). To some, the company represents the worst of Wall Street, an … Continue Reading
Read now